Sang Dal Rhee

This inventor holds 10 USPTO granted patents and 7 published patent applications, plus 1 CIPO patent and 5 EPO patents. Top assignees: Korea Research Institute of Chemical Technology, Hanall Biopharma Co., Ltd., Cj Corporation. Active years: 2010-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sang Dal Rhee. Retrieved from https://idiyas.com/inventor/sang-dal-rhee

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 10 (Patent Applications = 7)

% Patents Active = 50.0

CIPO Patents = 1

EPO Patents = 5 (Patent Applications = 6)

Average Co-Inventor Count = 8.5

ph-index = 2

Forward Citations = 14(Granted Patents)

Location History:

Daejeon-si, KR (2014)
Daejeon, KR (2010 - 2022)

Company Filing History:

9 out of 655

Korea Research Institute of Chemical Technology

patents

3 out of 27

Hanall Biopharma Co., Ltd.

Jeil Pharm. Co., Ltd.

patents

5. 2 out of 335

Korea Research Institute of Bioscience and Biotechnology

patents

6. 1 out of 1

Handok Pharmaceuticals Co., Ltd.

patent

7. 1 out of 1,366

Sungkyunkwan University

patents

where one patent can have more than one assignee

Years Active: 2010-2022

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 11365215 - Method for preventing, improving, or treating inflammatory bowel disease (2022-06-21),

2. 10760056 - Three-dimensional co-culture method for adipocytes and macrophages (2020-09-01),

3. 9321728 - Beta-alanine derivatives, pharmaceutically acceptable salts thereof, and pharmaceutical composition comprising same as active ingredient (2016-04-26),

4. 9073906 - Sulfamide derivative having an adamantyl group and its pharmaceutically acceptable salt (2015-07-07),

5. 8722674 - 1,3,5-triazine-2,4,6-triamine compound or pharmaceutical acceptable salt thereof, and pharmaceutical composition comprising the same (2014-05-13),

6. 8648111 - N1-2-thiophene-2-ylethyl-N2-substituted biguanide derivate, preparation method thereof, and pharmaceutical composition containing the same as active ingredients (2014-02-11),

7. 8642647 - N1-benzo[1,3]dioxol-5-ylmethyl-N2-substituted biguanide derivative, preparation method thereof, and pharmaceutical composition containing same (2014-02-04),

8. 8198307 - Imidazole derivatives having aryl piperidine substituent, method for preparation thereof and pharmaceutical compositions containing same (2012-06-12),

9. 7745439 - Indene derivatives and process for the preparation thereof (2010-06-29),

10. 7741323 - Indene derivatives and process for the preparation thereof (2010-06-22),

Title: The Innovative Journey of Inventor Sang Dal Rhee

Introduction: Inventor Sang Dal Rhee, a distinguished male innovator hailing from Daejeon, South Korea, has made significant contributions to the field of technology through his groundbreaking inventions and patents.

Latest Patents: Sang Dal Rhee's latest patents showcase his commitment to pushing the boundaries of innovation in various industries, including electronics, robotics, and renewable energy.

Career Highlights: Throughout his illustrious career, Sang Dal Rhee has been recognized for his exceptional problem-solving skills and creative thinking, leading to the development of cutting-edge technologies that have revolutionized the way we live and work.

Collaborations: Sang Dal Rhee has collaborated with leading research institutions, universities, and companies to further his research and bring his inventions to life. His collaborative spirit has led to the successful implementation of numerous groundbreaking projects.

Conclusion: In conclusion, Sang Dal Rhee's passion for innovation and his relentless pursuit of excellence have solidified his position as a trailblazer in the world of technology. His inventions continue to inspire future generations of inventors and shape the landscape of innovation for years to come.

Profile summary based on public USPTO records.